Dexcom (Nasdaq:DXCM) shares took a hit after hours today on third-quarter results that came in ahead of the consensus ...

After dealing with a deployment problem with glucose monitors earlier this year, interim CEO Jake Leach said improving ...

If you need to track your glucose daily, you probably want a pain-free option. Besides pricking your finger, there are now wearable devices that are placed on your arm and connect to an app on your ...

Q3 2025 Management View Interim CEO Jacob Leach reported "third quarter organic revenue growth of 20% compared to the third quarter of 2024" and highlighted "solid share performance in both our U.S.

Medical device maker Dexcom topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring systems.

Q3 2025 Earnings Call Transcript October 30, 2025 DexCom, Inc. beats earnings expectations. Reported EPS is $0.61, expectations were $0.57. Operator: Ladies and gentlemen, welcome to the DexCom Third ...